Medical Procedure News

RSS

ESC/EACTS releases new Myocardial Revascularisation guidelines

Multivessel and left main disease have been long considered as mainstay indications for coronary artery bypass grafting surgery (CABG). This recommendation, however, has been strongly challenged on several occasions. The release of new Myocardial Revascularisation guidelines by ESC and the European Association of Cardio-Thoracic Surgeons (EACTS) at the ESC Congress on Sunday 29 August is likely to shed new light on what has become a controversial topic.

31 Aug 2010

Bioheart's MyoCell adult stem cell therapy shows effective for heart failure patients: Study

Bioheart, Inc., The mission of the Cell Therapy Foundation is to improve public health through the support of effective adult stem cell research and education. The Foundation aims to promote basic and applied knowledge, processes and cell therapies.

31 Aug 2010

Study finds cognitive behaviour therapy safe for chronic fatigue syndrome

The aim of this study is to examine the frequency and severity of symptom deterioration during cognitive behaviour therapy (CBT) for chronic fatigue syndrome (CFS). Patients receiving CBT do not experience more frequent or more severe symptom deterioration than untreated patients. The reported deterioration during CBT seems to reflect the natural variation in symptoms. Thus, CBT is not only a helpful, but also a safe treatment for CFS.

31 Aug 2010

Genetic profiling to predict treatment benefits of ACE inhibitor therapy for CAD

The advantages of prescribing angiotensin-converting enzyme (ACE) inhibitors for stable coronary artery disease (CAD) may be increased by targeting the therapy to the patients most likely to benefit.Clinical characteristics alone do not allow a reliable identification of these patients, so a research programme was carried out at Erasmus University Medical Centre in Rotterdam to develop a genetic profiling model that predicts the treatment benefits of ACE inhibitors and optimises the recommended therapy.

31 Aug 2010

LESSON I trial provides evidence of benefits of everolimus-eluting stent over sirolimus-eluting stent

Results from the LESSON I trial presented today provide preliminary evidence for the therapeutic benefit of the newer generation everolimus-eluting stent over the previous gold standard, the early generation sirolimus-eluting stent. Moreover, LESSON I provides evidence that the formation of blood clots (stent thrombosis) - the principal shortcoming of early generation drug-eluting stents - may be diminished with the newer generation everolimus-eluting stent.

31 Aug 2010

Infants born by early elective C-section likely to have health problems: Study

Medical experts point to a disturbing trend of expectant mothers who are choosing to deliver their babies for non-medical reasons before 39 weeks of pregnancy.

31 Aug 2010

Using clopidogrel, PPIs increases cardiac damage risk: Study

Patients with coronary artery disease undergoing stent implantation are often prescribed the antiplatelet drug, clopidogrel. This drug prevents blood clots, but is known to have a side-effect that can cause stomach bleeding. Consequently, many users are also prescribed a proton pump inhibitor (PPI). Now, however, a meta-analysis of almost 160,000 patients carried out at the Medical University of Vienna and Wilhelminenhospital, Vienna, has shown that simultaneous use of these drugs can increase the risk of cardiac damage.

31 Aug 2010

Texas Children's Fetal Center announces 200th TTTS laser ablation surgery milestone

As one of the leading medical centers in the U.S. diagnosing and treating twin-to-twin transfusion syndrome (TTTS), Texas Children's Fetal Center is proud to announce the successful completion of its 200th TTTS laser ablation surgery.

31 Aug 2010

Data suggests BIMA improves coronary artery bypass graft efficiency

Recent trial data indicate that coronary artery bypass graft (CABG) surgery remains the most effective intervention for patients with severe coronary artery disease (CAD).

31 Aug 2010

African-Americans at higher risk of developing stent thrombosis

African-American race is a distinct risk factor for developing life-threatening blood clots after receiving a drug-coated stent, according to research reported in Circulation: Journal of the American Heart Association.

31 Aug 2010

Wellspring Cardiovascular and St. Anthony's Houston partner to reduce amputations

WELLSPRING CARDIOVASCULAR and ST. ANTHONY'S HOSPITAL announce a novel partnership in a move to dramatically reduce the number of amputations in the Houston area.

31 Aug 2010

First time use of ExAblate MR Guided Focused Ultrasound System for prostate cancer treatment

Elbit Imaging Ltd. that it's subsidiary, InSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients.

31 Aug 2010

SIR issues position statement to determine safety, effectiveness of interventional M.S. treatment

Recognizing that venous interventions may potentially play an important role in treating some patients who suffer from multiple sclerosis an incurable, disabling disease the Society of Interventional Radiology has issued a position statement indicating its support for high quality clinical research to determine the safety and effectiveness of interventional M.S. treatments.

31 Aug 2010

J-LANCELOT trial finds E5555 may reduce MACE without increasing serious bleeding events

Aspirin and thienopyridine antiplatelet therapy (such as clopidogrel) are standard care in the treatment of acute coronary syndrome (ACS) and even in stable coronary artery disease (CAD) after coronary intervention with stent. However, effective antiplatelet agents are needed which do not increase the risk of bleeding.

31 Aug 2010

Antithrombotic therapy increases bleeding risk in CAD patients: Research

Antithrombotic therapy using antiplatelet and anticoagulant agents is the cornerstone of treatment for acute and chronic coronary artery disease (CAD), yet it is also associated with an increased risk of bleeding. It is paradoxical that elderly patients, the most likely population to develop CAD, are those that suffer most from bleeding complications.

31 Aug 2010

First UK PyroTITAN Humeral Resurfacing Implant performed at BMI - The Alexandra Hospital

Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic devices, announces the implantation of the first PyroTITAN™ Humeral Resurfacing Implant in the United Kingdom. The PyroTITAN was implanted at BMI - The Alexandra Hospital in Cheadle, Cheshire.

31 Aug 2010

Study: Explosion of medical imaging due partly to overuse

"Part of the explosion in medical imaging over the past two decades may be attributable to overuse, and steps need to be taken to cut back," according to a study in the journal Radiology, MedPage Today/ABC News reports.

30 Aug 2010

MRI recordings at one fiftieth of a second

"Please hold absolutely still": This instruction is crucial for patients being examined by magnetic resonance imaging (MRI). It is the only way to obtain clear images for diagnosis. Up to now, it was therefore almost impossible to image moving organs using MRI. Max Planck researchers from G-ttingen have now succeeded in significantly reducing the time required for recording images - to just one fiftieth of a second.

30 Aug 2010

Perfadex improves survival in lung tranplant patients: Study

A recently published study in The Journal of Heart and Lung Transplantation shows that the patients who are most seriously ill before lung tranplantation have better one-year survival when Perfadex is used as the preservation solution for donor lungs compared with UW solution. Furthermore, the patients who received lungs preserved in Perfadex ran a significantly lower risk of being affected by rejection reactions requiring treatment.

30 Aug 2010

AMS enters 10-year contract to supply radiation therapy services at Hospital Santa Paula, Brazil

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that it has entered into a ten-year contract to supply radiation therapy services at Hospital Santa Paula (HSP) in São Paulo, Brazil. AMS will place an advanced technology linear accelerator with IMRT capabilities at HSP, and is expected to begin treating patients in early 2012 in conjunction with the expected completion of a new comprehensive cancer center to be built by the hospital.

30 Aug 2010

Medical Procedure News

ESC/EACTS releases new Myocardial Revascularisation guidelines

Bioheart's MyoCell adult stem cell therapy shows effective for heart failure patients: Study

Study finds cognitive behaviour therapy safe for chronic fatigue syndrome

Genetic profiling to predict treatment benefits of ACE inhibitor therapy for CAD

LESSON I trial provides evidence of benefits of everolimus-eluting stent over sirolimus-eluting stent

Infants born by early elective C-section likely to have health problems: Study

Using clopidogrel, PPIs increases cardiac damage risk: Study

Texas Children's Fetal Center announces 200th TTTS laser ablation surgery milestone

Data suggests BIMA improves coronary artery bypass graft efficiency

African-Americans at higher risk of developing stent thrombosis

Wellspring Cardiovascular and St. Anthony's Houston partner to reduce amputations

First time use of ExAblate MR Guided Focused Ultrasound System for prostate cancer treatment

SIR issues position statement to determine safety, effectiveness of interventional M.S. treatment

J-LANCELOT trial finds E5555 may reduce MACE without increasing serious bleeding events

Antithrombotic therapy increases bleeding risk in CAD patients: Research

First UK PyroTITAN Humeral Resurfacing Implant performed at BMI - The Alexandra Hospital

Study: Explosion of medical imaging due partly to overuse

MRI recordings at one fiftieth of a second

Perfadex improves survival in lung tranplant patients: Study

AMS enters 10-year contract to supply radiation therapy services at Hospital Santa Paula, Brazil

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News